SAVOIA, Paola
 Distribuzione geografica
Continente #
EU - Europa 12.768
NA - Nord America 7.322
AS - Asia 2.165
SA - Sud America 99
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 36
OC - Oceania 29
Totale 22.461
Nazione #
IT - Italia 7.725
US - Stati Uniti d'America 7.210
CN - Cina 1.111
IE - Irlanda 935
FR - Francia 823
DE - Germania 634
KR - Corea 575
FI - Finlandia 511
UA - Ucraina 461
SE - Svezia 441
GB - Regno Unito 274
PL - Polonia 273
AT - Austria 219
VN - Vietnam 136
IN - India 128
CA - Canada 90
JP - Giappone 77
CH - Svizzera 72
ES - Italia 68
BE - Belgio 63
BR - Brasile 51
DK - Danimarca 43
EU - Europa 35
NL - Olanda 34
GR - Grecia 26
TR - Turchia 26
AU - Australia 25
RU - Federazione Russa 25
SN - Senegal 25
RO - Romania 24
AR - Argentina 19
HR - Croazia 17
UZ - Uzbekistan 16
MX - Messico 15
SG - Singapore 14
TW - Taiwan 14
CL - Cile 13
CZ - Repubblica Ceca 13
PT - Portogallo 13
SI - Slovenia 13
HK - Hong Kong 10
NO - Norvegia 10
TH - Thailandia 9
CO - Colombia 7
HU - Ungheria 7
PE - Perù 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
EG - Egitto 6
ID - Indonesia 6
IL - Israele 6
LV - Lettonia 6
BY - Bielorussia 5
IR - Iran 5
QA - Qatar 5
ZA - Sudafrica 5
BG - Bulgaria 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
PH - Filippine 4
RS - Serbia 4
BA - Bosnia-Erzegovina 3
DZ - Algeria 3
LB - Libano 3
LT - Lituania 3
LU - Lussemburgo 3
MK - Macedonia 3
PA - Panama 3
EC - Ecuador 2
EE - Estonia 2
JO - Giordania 2
MD - Moldavia 2
MN - Mongolia 2
MT - Malta 2
A1 - Anonimo 1
CR - Costa Rica 1
CY - Cipro 1
GT - Guatemala 1
HN - Honduras 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
SK - Slovacchia (Repubblica Slovacca) 1
TC - Turks e Caicos 1
TN - Tunisia 1
Totale 22.461
Città #
Chandler 1.000
Dublin 925
Beijing 796
Villeurbanne 471
Milan 445
Rome 376
Princeton 369
Houston 345
Medford 344
Jacksonville 332
Ann Arbor 304
Ashburn 271
Fairfield 247
Warsaw 243
Torino 239
Vienna 212
Wilmington 212
Dearborn 196
Woodbridge 154
Nyköping 130
Florence 125
Redwood City 122
Turin 110
Pisa 104
Seattle 103
Naples 96
Cambridge 86
Dong Ket 84
Palermo 82
Bologna 69
Verona 62
Boardman 60
Fremont 58
Boston 55
Padova 55
Brussels 54
Bari 52
Genoa 52
Pune 51
Brescia 43
Napoli 43
Trieste 43
Nanjing 38
Washington 35
Catania 32
New York 32
Shanghai 31
Norwalk 30
Toronto 30
Genova 29
Tokyo 28
Guangzhou 27
Modena 27
Falls Church 26
Pescara 24
Bergamo 23
Treviso 23
Helsinki 22
Hefei 21
Kunming 21
Dallas 20
Mountain View 20
Novara 20
Saluzzo 20
Venice 20
Lachine 19
Messina 19
San Mateo 19
London 18
Reggio Emilia 18
Chengdu 17
Livorno 17
Parma 16
Des Moines 15
Hangzhou 15
Munich 15
Nürnberg 15
San Diego 15
Scafati 15
Trento 15
Como 14
Paris 14
Valdagno 14
Zurich 14
Hebei 13
Venezia 13
Athens 12
Madrid 12
Mumbai 12
Ottawa 12
Berlin 11
Brno 11
Iesi 11
Lucca 11
Mestre 11
Monza 11
Phoenix 11
Rimini 11
Santiago 11
Sassari 11
Totale 10.307
Nome #
Ulcerazione e regressione: ruolo prognostico 3.805
Linfonodo sentinella negativo e progressione di malattia nel melanoma: aspetti clinici e prognostici 1.959
Blood Flow Cytometry in Sézary Syndrome: New Insights on Prognostic Relevance and Immunophenotypic Changes During Follow-up. 429
Le dermatosi paraneoplastiche. Introduzione, il concetto di dermatosi paraneoplastica. Inquadramento diagnostico. 390
Malattie bollose autoimmuni: casisitica clinica e approccio terapeutico 374
Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre. 353
Intestinal involvement in toxic epidermal necrolysis. A case report and review of literature. 292
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study 289
Complete regression of melanoma skin metastases after electrochemotherapy plus ipilimumab treatment: An unusual clinical presentation 281
Metastasi cutanee da melanoma: l’esperienza della I Clinica Dermatologica di Torino 278
Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients. 276
Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid 258
Efficacia della fotochemioterapia extracorporea nel trattamento di un caso di lichen erosivo 252
Metastasi ossee da melanoma: incidenza e impatto sulla sopravvivenza 241
Effectiveness of extracorporeal photochemotherapy in the treatment of a case of refractory erosive lichen planus 241
Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review 232
Differences in clinicopathological features and distribution of risk factors in Italian melanoma patients 206
Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: the experience of the Italian immuno-pathology group 205
Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas 196
Effectiveness of electrochemotherapy in treatment of a recurrent squamous cell carcinoma of the scalp. 183
Patologie dermatologie e rischio di neoplasia in pazienti portatori di trapianto di rene: revisione della casistica torinese 181
Malattia di Castleman multicentrica associata a sarcoma di Kaposi Savoia P, Fierro MT, Quaglino P, Zaccagna A, Bernengo MG 172
Relevance of multiple basin drainage and primary histologic regression in prognosis of trunk melanoma patients with negative sentinel lymph nodes. 168
Adult-onset cutaneous mastocytosis in monozygotic twins. 165
Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients. 164
Dermatite Flagellata e Melanonichia striata longitudinale da citostatici 162
Usefulness of photodynamic therapy as a possible therapeutic alternative in the treatment of basal cell carcinoma 147
Rischio di recidiva ed intervallo libero da malattia: linee guida di terapia e follow-up. 127
Halo nevi related to treatment with imatinib in a dermatofibrosarcoma protuberans patient 126
miR-155 expression in Primary Cutaneous T-Cell Lymphomas (CTCL) 124
Precursori del melanoma? 123
Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: A single centre observational cohort study. 116
Dermatite flagellata e iperpigmentazione longitudinale a banda ungueale indotta da trattamento chemioterapico: descrizione di un caso. 108
Fotoferesi: applicazioni terapeutiche “off-label” 108
Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients. 106
Studio citofluorimetrico della popolazione circolante CD4+CD27+ nelle eritrodermie infiammatorie e nei linfomi cutanei: relazione con i livelli di cellule CD4+CD26- ed utilità diagnostica. 105
Dermatite flagellata e melanonichia striata longitudinale da citostatici. 102
Linfociti circolanti T regolatori in pazienti psoriasici trattati con ciclosporina e farmaci biologici 101
Dermatofibrosarcoma protuberans: studio retrospettivo sui pazienti trattati negli ultimi 10 anni 100
Associazione di etoposide, idarubicina, ciclofosfamide, vincristina, prednisone e bleomicina (VICOP-B) nel trattamento dei linfomi cutanei 100
Manifestazioni cutanee correlate al trattamento con imatinib mesilato in pazienti affetti da dermatofibrosarcoma protuberans 95
Congenital Sensorineural Hearing Loss and Inborn Pigmentary Disorders: First Report of Multilocus Syndrome in Piebaldism 95
β-HPV infection correlates with early stages of carcinogenesis in skin tumors and patient-derived xenografts from a kidney transplant recipient cohort 95
Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes 93
Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients. 91
Malattia di Destombes-Rosai-Dorfman ad esclusivo interessamento cutaneo: studio istologico, immunoistochimico ed ultrastrutturale di un caso. 88
Linfoma cutaneo CD56 positivo: presentazione di un caso 88
Adhesion molecules in lymphomatoid granulomatosis 84
VEGF-165 serum levels and tyrosinase expression in melanoma patients: correlation with the clinical course. 84
Morfea profonda infiammatoria disseminata: presentazione di un caso. 81
Collagenase digestion and mechanical disaggregation as a method to extract and immunophenotype tumour lymphocytes in cutaneous T-cell lymphomas. 80
Improvement of sensitivity in sentinel lymph node procedure in melanoma patients. 79
Altered expression of HLA-A,B specificities on acute lymphoid and myeloid leukaemia blasts. 78
Clinical and prognostic reports from 270 patients with multiple primary melanomas: a 34-year single-institution study 78
Associazione di ciclofosfamide, vincristina e prednisone (COP) nel trattamento dei linfomi cutanei: 20 anni di follow-up. 78
Traditional urinary cytology and tyrosinase RT-PCR in metastatic melanoma patients: correlation with clinical status 77
Metastasi cutanee da melanoma ad aspett ozosteriforme: report di un caso e revisione della letteratura 76
Electrochemotherapy in treatment of skin melanoma metastases 75
Un caso di leucemia/linfoma a cellule T dell'adulto con localizzazioni cutanee: caratteristiche cliniche, istologiche ed immunologiche 74
A monoclonal antibody identifies a novel GPI-anchored glycoprotein involved in epithelial intercellular adhesion. 73
Characterization and management of cutaneous side effects related to the immunosuppressive treatment in solid organ recipients 72
A membrane glycoprotein identified by the monoclonal antibody BD31 is a component of cell-cell junctions of normal and transformed epithelia. Eur J Cell Biol, 55 (Suppl 35): 54, 1991 72
Guess what? Inflammatory disseminated morphea profunda. 71
CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients. 71
Cutaneous melanoma metastases arising on a split-skin graft donor site 70
Linfociti Treg e fotoferesi 70
Adhesion molecules in the control of cell proliferation and cell motility. 70
Activity Of Imatinib Mesilate In Metastatic Melanoma 70
CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma 70
A novel GPI-anchored glycoprotein shows properties of a COOH-terminus truncated cadherin involved in cell-cell contacts of cultured human epithelial cells. 69
Altered expression of alpha 6 integrin subunit in oral squamous cell carcinoma and oral potentially malignant lesions. 68
Alemtuzumab nel trattamento dei linfomi cutanei a cellule T in fase avanzata: studio pilota “dose finding”. 68
CD26 expression on cutaneous infiltrates from patients CD26 expression on cutaneous infiltrates from patients with cutaneous T-cell lymphoma (CTCL) CD26 in cutaneous T-cell lymphoma patients. 67
Clinical significance of sequential tyrosinase expression in the peripheral blood of disease-free melanoma patients: a review of literature data 67
Progressione di malattia nei pazienti affetti da melanoma con linfonodo sentinella negativo 67
After Surgery: Follow-Up Guidelines of Melanoma Patients 66
Bullous, cutaneous, pleomorphic T-cell Lymphoma: analysis of integrins and extracellular matrix components. 66
Distribution of integrins and extracellular matrix proteins in vulvar squamous cell carcinomas. 65
What is the role of sequential reverse-transcriptase polymerase chain reaction analysis of melanoma-specific mRNA in the peripheral blood of melanoma patients? 65
FoxP3 expression on melanoma cells is related to early visceral spreading in melanoma patients treated by electrochemotherapy. 65
Determinazione della tirosinasi mediante RT-PCR nel follow-up del melanoma 65
Calcinosi cutanee atipiche in paziente portatrice di trapianto renale: tumor calcinosis familiare? 65
Zosteriform cutaneous metastases: a literature meta-analysis and a clinical report of three melanoma cases 64
Time course and pattern of first relapse in stage I-II primary cutaneous melanoma: a multivariate analysis of disease-free survival in 3,174 patients followed-up at the Turin Melanoma Centre from 1975 to 2004 63
CD26 expression on keratinocytes in normal skin, inflammatory skin diseases and cutaneous T-cell lymphomas (CTCL). 63
Clinic-pathologic features of sentinel lymph nodes predictive for non-sentinel lymph node involvement, disease-free survival and overall survival in melanoma patients 63
The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells. 63
Therapeutic approaches in advanced mycosis fungoides and Sezary Sindrome. A 30-year single institution experience 62
Biological prognostic factors in advanced metastatic melanoma patients treated with chemoimmunotheraphy. 62
Melanomi primitivi multipli: analisi di 49 casi. 62
Ulcere difficili: forme autoimmuni e infiammatorie. 62
Quantitative expression of HLA class I molecules in acute non-lymphoblastic leukaemia cells. 61
Eletro-quimioterapia - terapia inovativa de metastase cutanea de melanoma e outros tuimores solidos 61
Utilità dell’RT-PCR per la tirosinasi nel monitoraggio dei pazienti affetti da melanoma in stadio III. 61
Circulating CD4+CD25 bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients. 60
Index risk on sentinel lymph nodes features that could predict non-sentinel lymph node involvement, disease-free survival and overall survival in melanoma patients. 60
Electrochemotherapy with intravenous Bleomycin in the treatment of cutaneous. Metastases: a prospettive single center experience with long term follow-up data 60
FOXP3 AND MELANOMA: THE BIG ESCAPE? 60
Cutaneous Adverse Events Related To Treatment With Imatinib 60
Clinical presentation and immunological features of an Italian ATL case 60
Totale 17.613
Categoria #
all - tutte 47.056
article - articoli 0
book - libri 0
conference - conferenze 24.249
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.305


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019850 0 0 0 0 0 0 0 0 126 179 351 194
2019/20202.746 153 130 201 341 238 341 313 206 225 240 164 194
2020/20212.473 389 141 199 156 199 169 160 121 248 233 188 270
2021/20222.468 110 91 131 199 188 114 128 134 127 128 412 706
2022/20235.218 567 304 184 385 437 998 579 540 577 143 275 229
2023/20242.297 333 329 288 217 205 279 244 329 73 0 0 0
Totale 23.208